Table 6.

Resynchronization therapy in patients with RHF.

Study	Study population	Characteristics	N	Design	Main findings *
Janousek et al. 2001 [84]	Congenital Heart disease	Children with acute post-operative HF with conduction delay	20	Prospective study	Beneficial effects. Improvement in hemodynamics (systolic blood pressure)
Dubin et al. 2003 [85]	Congenital Heart disease	Chronic RV dysfunction RBBB TOF, aortic stenosis after Ross procedure	7	Prospective Multipacing sites, conductance catheter	Beneficial effect. Atrioventricular augments RV and systemic performance (↑CI by 17±8%,↑ in RV dP/dt )
Janousek et al. 2004 [86]	Congenital Heart Disease	D-TGA (atrial baffle) L-TGA	8	Prospective	Beneficial effect. ↑ RVEF by 9.6%, ↓ RVMPI by 7.7%.
Dubin et al. 2005 [87]	Congenital Heart Disease and Pediatric	CHD and dilated CMP and congenital AV block	103	Multicenter Study (22 centers)	Beneficial effects in all 3 groups. Average ↑ in EF 11.9% to 16.1%. Responders had lower baseline EF.

^*Unless otherwise specified, the results refer to statistically significant findings (p<0.05). The changes reported refer to relative changes in mean effect size or when indicated by ‡ changes in absolute effect size. Abbreviations as in previous tables. EF indicates ejection fraction, RVMPI indicates RV myocardial performance index